ACE2 and acute respiratory distress syndrome caused by 2019 novel coronavirus
DOI:
CSTR:
Author:
Affiliation:

1.Graduate School of Hebei Medical University, Shijiazhuang, Hebei 050017, China;2.Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050000, China)

Clc Number:

R5

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The 2019 novel coronavirus (2019-nCoV) was discovered in an unidentified viral pneumonia case in Wuhan, China in December 2019, and was named by the World Health Organization (WHO) on January 2,0. The disease caused by 2019-nCoV was named corona virus disease 2019 by WHO on February 2,0. Recent studies have shown that angiotensin converting enzyme 2 (ACE2) is likely to be a mediating receptor of 2019-nCoV-infected cells, and ACE2 is mostly expressed in type Ⅱ alveolar cells in the human lung cells. The high expression of ACE2 in type Ⅱ alveolar cells may explain acute respiratory distress syndrome (ARDS) after 2019-nCoV infection. The first completed pathologic dissection of a patient who died of 2019-nCoV-pneumonia revealed diffuse alveolar injury and lung transparent membrane formation, consistent with ARDS.

    Reference
    Related
    Cited by
Get Citation

ZHANG Xiaoqing, LI Shuren, NIU Shaoqian. ACE2 and acute respiratory distress syndrome caused by 2019 novel coronavirus[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(5):395-399.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 17,2020
  • Revised:March 17,2020
  • Adopted:
  • Online: May 26,2020
  • Published:
Article QR Code